Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records